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Effects of antioxidant vitamins on hypoxia-induced erythropoietin
production. An important role in 02 sensing has been assigned to
microsomal and membrane-bound b-type cytochromes which generate
regulatory reactive 02 species (ROS). Recently, ROS have been shown to
suppress the in vitro synthesis of erythropoietin (Epo). We investigated the
potential of the antioxidant vitamins A, E and C to enhance renal and
hepatic Epo production. Renal effects were studied in isolated serum-free
perfused rat kidneys. In control experiments without antioxidant vitamins,
Epo secretion amounted to 441 23 mU/g kidney (mean SuM, N = 5)
during the three hour period of hypoxic perfusion (arterial P°2 35 mm
Hg). Epa secretion significantly increased to 674 92 mU/g kidney (N =
7) when vitamins A (0.5 g/ml), E (0.5 j.rglml) and C (10 pg/mI) in
combination were added to the perfusion medium. The effects of the
single vitamins were studied in Epo-producing hepatoma cell cultures
(lines HepG2 and Hep3B). Vitamin A induced a dose-dependent increase
(half-maximal stimulation at 0.2 /.Lg/ml) in the production of immunore-
active Epo during 24 hours of incubation (such as 680 51 U Epo/g cell
protein in HepG2 cultures with 3 pg/mI retinol acetate compared to 261
15 U/g in untreated controls; N = 4). In contrast, vitamin E (tested from
0.05 to 500 J.Lg/ml) and vitamin C (tested from 2 to 200 j.g/ml) did not
increase Epo production in hepatoma cell cultures. Thus, while vitamins E
and C may have the potential to protect cells from oxidative damage,
vitamin A exerts a specific stimulation of Epo production. Preliminary
evidence suggests that this effect of vitamin A involves increased mRNA
levels of hypoxia-inducible factor irs (HIF-la)
Hemoproteins are involved in 02 sensing in various tissues. An
important role has been assigned to microsomal and membrane-
bound b-type cytochromes because they generate reactive 02
species such as H202 [1, 2], which may oxidize sulfhydryl-groups
of regulatory proteins. With respect to the synthesis of erythro-
poietin (Epo) we have previously shown that the in vitro produc-
tion of H202 is dependent on °2 tension (P°2) and that H202
suppresses Epo gene expression [3].
The present in vitro study investigated the potential of the
antioxidant vitamins A, E and C to enhance renal and hepatic Epo
synthesis. Renal effects were studied in isolated perfused rat
kidneys. Hepatic synthesis of Epo was studied in cultures of the
human hepatoma cell lines HepG2 and I-lep3B. Hypoxic induc-
tion of Epo gene expression is critically dependent on activation
of an enhancer element located at the 3' flanking region of the
Epo gene. This enhancer is responsive to binding of a protein
complex termed hypoxia-inducible factor 1 (HIF-1), which is
composed of at least two subunits that have been designated
HJF-lcs and HIF-1f3 [4, 5]. Therefore, in addition Northern blots
© 1997 by the International Society of Nephrology
for HIF-Ics mRNA were performed to detect a possible increase
in the mRNA level for HIF-ics.
Methods
Kidney perfusion
To study renal Epo production, kidneys from adult male
Sprague-Dawley rats were perfused at constant pressure (100 mm
Hg) in a recirculation system for three hours as described in [6].
Where indicated, antioxidant vitamins were added to the perfu-
sion medium (retinol acetate 0.5 pg/mI, cs-tocopherol 0.5 rg/ml,
vitamin C 10 pg/mI; all obtained from Sigma, MUnchen, Germa-
ny). The perfusion medium was a substrate and amino acids
enriched Krebs-Henseleit solution supplemented with 60 glliter
albumin and 5% human erythrocytes. It was dialyzed against a
25-fold volume of a protein- and cell-free medium. Epo was
measured by enzyme-linked immunoassay in samples of the
perfusion medium. The assay was carried out according to the
manufacturer (EPO-ELISA Test; Medac GmbH, Hamburg, Ger-
many), except that rat serum Epo previously calibrated by bioas-
say was used as the standard instead of human Epo.
Hepatoma cell cultures
The human hepatoma cell lines HepG2 (ATCC No. 8065) and
Hep3B (ATCC No. 8064) were used to study effects of single
antioxidant vitamins on Epo production. The cells were main-
tained in RPMI 1640 medium supplemented with 10% fetal
bovine serum (Sigma) and NaHCO3 (2.2 g/liter) in a humidified
atmosphere (5% CO2 in air) at 37°C (Heraeus Incubators, Hanau,
Germany). Cell monolayers were grown to confluence in 24-well
polystyrene dishes (Falcon, Becton Dickinson, Heidelberg, Ger-
many). The cultures had a density of 5 >< iO cells/cm2 when used.
The medium (0.5 ml/cm2) was renewed 24 hours before the
experiment.
For study of Epo secretion, cells in 24-well polystyrene dishes
were incubated with the respective vitamin in air-5% CO2 for 24
hours. Under these conditions, 3 to 10 U Epo per hour and g
cellular protein were usually produced because the cultures were
hypoxic due to a diffusion-limited 02 supply [7]. The medium was
collected after 24 hours of incubation and frozen at —20°C. Epo
was measured by radioimmunoassay as described earlier [7]. The
cell layer was washed with phosphate buffered saline and lysed
with SDS/NaOH (5 g/liter sodium dodecyl sulfate in 0.1 M NaOH).
Total cellular protein was determined by a micro-determination
kit (Sigma Diagnostics, Taufkirchen, Germany).
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Cytotoxicity was assessed by means of the [3-(4,5-dimethylthia- To study HIF-la gene expression, cells were grown to conflu-
zol-2-yl}-2,5-diphenyl}tetrazolium bromide assay (MTT) as re- ence in culture dishes with a gas-permeable bottom (3.5 cm
cently described [8]. diameter; Petriperm, Heraeus, Germany). After 10 hours of
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Fig. 1. Time-course of the production of Epo by isolated perfused rat kidneys Fig. 2. Effect of antioxidant vitamins (retinol acetate 0.5 pg/mI, a-tocoph-
and its dependence on arterial P°2 (means SEM N = 5). erol 0.5 pg/mI, vitamin C 10 pg/mi) on the three hours rate of the production
of Epo in isolated hypoxically (arterial P°2 35 mm Hg) perfused rat kidneys
(means SEM, exp. no. at the bottom, 'P < 0.05 compared to controls).
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Fig. 6. Northern-hybridization on RNA ofHep3B
cell extracts with a HIF-]a probe (top) and
corresponding gel (bottom). Cells were incubated
with 1 g/ml vitamin A for 10 hours under
normoxic and hypoxic conditions.
hypoxic incubation (2% 02) at 37°C, RNA was isolated with the
commercially available Trizol reagent (GIBCO BRL, Eggenstein,
Germany) following the instructions of the manufacturer (this
method is a modification of the single step protocol developed by
Chomczynski and Sacchi [9]). RNA concentrations were determi-
nated by measuring the optical density at 260 nm. RNA was
separated in 1.4% agarose gel containing 0.7 M formaldehyde and
visualized according to Gong [101. After separation, the RNA was
transferred onto Nylon membranes (Nytran plus; Schleicher &
SchUll, Dassel, Germany) using a vacuum blotting apparatus
(Pharmacia, Freiburg, Germany) and fixed to the membran by
UV-irradiation. Finally, the membrane was baked for 1.5 hours at
80°C and stored dry in the dark until hybridization. Hybridization
was performed in 45% formamide, 5 x sodium chloride sodium
citrate (SSC), 5 X Denhardt's solution, 0.1% SDS and 100 rg/ml
sonicated denatured salmon testis DNA at 42°C for 36 to 48
hours. After hybridization filters were washed twice for 15 min-
utes in 0.2 >< SSC/0.1% SDS at 50°C, sealed in plastic bags and
exposed to autoradiographic films at —80°C for varying time
intervals.
HIF-1 a probe is a 542 bp PCR-fragment generated by primers:
5' GTC GGA CAG CCT CAC CAA ACAG 3' (upstream primer)
and 5' TAG GTA GTG AGC CAC CAG TGT CC 3' (down-
stream primer). Primer sequences were derived from the HIF-1 a
nucleotide sequence published by Wang et al [4]. PCR-tempera-
ture profiles were one minute at 93°C, 1.30 minutes at 57°C and
two minutes at 72°C for 35 cycles. Labeling was done using a
random prime labeling kit (Boehringer, Mannheim, Germany)
and a(32P) dCTP (3000 Ci/mmol).
Statistics
Data are expressed as the mean standard error (sEM).
Student's t-test was applied for estimation of significance (P <
0.05) of the differences between two group means. Dunnett's test
was applied to compare a control mean with several treatment
means.
Results
Figure 1 shows that isolated perfused rat kidneys produced Epo
in a p02-dependent manner. The rate of Epo production was
significantly increased when vitamins A, E and C in combination
were added to the perfusion medium (Fig. 2).
Studies in HepG2 and Hep3B cultures showed that only vitamin
A increased the rate of Epo production (Figs. 3 and 4). In
contrast, vitamins E (dose range 0.05 to 500 ,ag/ml; data not
shown) and C (Fig. 5) were without effect over a wide dosage
range. Based on the MYT assay none of the vitamins was cytotoxic
in the dose range under study.
kb
—7.47
—4.40
—2.37
—7.47
— 4.40
—2.37
Jelkmann et al: Vitamins and eiythropoietin production 501
Northern blots with total RNA from untreated and from
vitamin A-treated Hep3B cells revealed a possible increase in
HIF-la mRNA levels by vitamin A treatment (Fig. 6).
Discussion
The antioxidant vitamins A, E and C increased the concentra-
tion of immunoreactive Epo in the perfusate of isolated perfused
rat kidneys when added in combination to the perfusion medium.
This result indicated that at least one of the vitamins was capable
of stimulating renal Epo production. When the single vitamins
were tested in the human hepatoma cell lines HepG2 and Hep3B,
only vitamin A proved to increase the concentration of immuno-
reactive Epo in the culture medium. Okano et at [11] have
proposed earlier that vitamin A activates Epo gene transcription,
because Epo mRNA levels are elevated in vitamin A-treated
HepG2 cultures.
A renal cell culture model for the study of p02-dependent Epo
production has not yet been established. Thus, most of the
knowledge of the molecular mechanisms of the control of Epo
gene expression has been based on experiments with human
hepatoma cells. The accumulation of Epo mRNA following the
induction of hypoxia results in these cells both from activated Epo
gene expression and increased mRNA stability [12]. Cis-acting
DNA-sequences neighboring the Epo gene mediate hypoxia in-
ducibility both as promoter and enhancer elements [13—15]. HIF-1
is presently considered the main transcription factor in the control
of the Epo gene [4, 5]. HIF-1 is composed of two subunits, HIF-ics
and HIF-1f3, with the latter being identical to the aryl hydrocar-
bon receptor nuclear translocator, ARNT [41.
The present Northern blotting experiments resulted in in-
creased HIF-la mRNA levels in vitamin A-treated Hep3B cells.
This observation clearly needs to be inspected by a more quanti-
tative assay of HIF-la mRNA. Clarification of this issue is crucial
for the interpretation of the present results. If vitamin A increases
HIF-1 mRNA levels, it is likely that this vitamin interferes with
the 02 sensing mechanism.
An alternative explanation for the vitamin A effect might be
that retinoic acid receptors bind to a steroid responsive element
(DR-2 sequence) in the 3'-enhancer region of the Epo gene [11].
However, the expression of a reporter gene linked to the Epo
3'-enhancer region was not stimulated by retinoic acid in Hep3B
cells [151.
Carotenoids are considered antioxidants because of their Ca-
pacity to scavenge reactive 02 species [16]. Therefore, the present
findings are in agreement with the hypothesis hat reactive °2
species are inhibiting signals in Epo synthcsis [2, 3]. It still needs
to be clarified as to why several other antioxidant compounds—
including vitamins E and C—do not stimulate Epo production.
Because of its lipophilic property vitamin E, similar to vitamin A,
acts preliminary in lipid-rich membranes, where it converts °2
radicals to less reactive forms [16]. With respect to the action of
vitamin C, it has to be noted that this it is hydrophilic and that it
may act both as an antioxidant and prooxidant. The present study
shows that vitamin C did not stimulate Epo production. Neither
does it induce HIF-1 DNA-binding activity [5].
Reprint requests to Wolfgang Jelkmann, M.D, Institute of Physiology,
Medical University of Luebeck, Ratzeburger Allee 160, D-23538 Luebeck,
Germany.
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